AstraZeneca pauses coronavirus vaccine trial, shares slip on rollout doubts

By Reuters, published by US News London – AstraZeneca has suspended global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, knocking the British drugmaker’s shares today (Sept. 9) as prospects for an early rollout dimmed. The vaccine to combat Covid-19, which AstraZeneca is developing with the University of Oxford, has

Read more